<p>A crystalline compound of formula (1) and its salts and solvates are provided for the treatment or prophylaxis of hepatitis C virus infections (1) Methods of making and formulating crystalline compound (1) are provided.</p>
申请公布号
WO2009009001(A1)
申请公布日期
2009.01.15
申请号
WO2008US08259
申请日期
2008.07.03
申请人
GILEAD SCIENCES, INC.;K.U. LEUVEN RESEARCH & DEVELOPMENT;PUERSTINGER, GERHARD;DOWDY, ERIC, D.;KENT, KENNETH, M.;TOM, NORMA, J.;ZIA, VAHID
发明人
DOWDY, ERIC, D.;KENT, KENNETH, M.;TOM, NORMA, J.;ZIA, VAHID
